Korten, V. Et Al. 2019. Clinical experience of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide (E/C/F/TAF) in real life practice: data from the Turkish HIV-TR cohort. HIV MEDICINE , vol.20 , 58.

Korten, V., Inan, A., Akalin, H., Gokengin, D., Kaya, B., Inan, D., ... Ozdemir, H. O.(2019). Clinical experience of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide (E/C/F/TAF) in real life practice: data from the Turkish HIV-TR cohort. HIV MEDICINE , vol.20, 58.

Korten, V. Et Al. "Clinical experience of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide (E/C/F/TAF) in real life practice: data from the Turkish HIV-TR cohort," HIV MEDICINE , vol.20, 58, 2019

Korten, V. Et Al. "Clinical experience of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide (E/C/F/TAF) in real life practice: data from the Turkish HIV-TR cohort." HIV MEDICINE , vol.20, pp.58, 2019

Korten, V. Et Al. (2019) . "Clinical experience of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide (E/C/F/TAF) in real life practice: data from the Turkish HIV-TR cohort." HIV MEDICINE , vol.20, p.58.

@article{article, author={V. Korten Et Al. }, title={Clinical experience of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide (E/C/F/TAF) in real life practice: data from the Turkish HIV-TR cohort}, journal={HIV MEDICINE}, year=2019, pages={58} }